» Articles » PMID: 24607545

RASSF Tumor Suppressor Gene Family: Biological Functions and Regulation

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2014 Mar 11
PMID 24607545
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Genetic changes through allelic loss and nucleic acid or protein modifications are the main contributors to loss of function of tumor suppressor proteins. In particular, epigenetic silencing of genes by promoter hypermethylation is associated with increased tumor severity and poor survival. The RASSF (Ras association domain family) family of proteins consists of 10 members, many of which are tumor suppressor proteins that undergo loss of expression through promoter methylation in numerous types of cancers such as leukemia, melanoma, breast, prostate, neck, lung, brain, colorectal and kidney cancers. In addition to their tumor suppressor function, RASSF proteins act as scaffolding agents in microtubule stability, regulate mitotic cell division, modulate apoptosis, control cell migration and cell adhesion, and modulate NFκB activity and the duration of inflammation. The ubiquitous functions of these proteins highlight their importance in numerous physiological pathways. In this review, we will focus on the biological roles of the RASSF family members and their regulation.

Citing Articles

Maternal weight during pregnancy and risk of childhood acute lymphoblastic leukemia in offspring.

Liu J, Kharazmi E, Liang Q, Chen Y, Sundquist J, Sundquist K Leukemia. 2025; 39(3):590-598.

PMID: 39865137 PMC: 11879861. DOI: 10.1038/s41375-025-02517-6.


Prostate Cancer Progression Modeling Provides Insight into Dynamic Molecular Changes Associated with Progressive Disease States.

Chen R, Tang L, Melendy T, Yang L, Goodison S, Sun Y Cancer Res Commun. 2024; 4(10):2783-2798.

PMID: 39347576 PMC: 11500312. DOI: 10.1158/2767-9764.CRC-24-0210.


DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease.

Zhou J, Li L, Zhang H, Agborbesong E, Harris P, Calvet J Kidney Int. 2024; 106(2):258-272.

PMID: 38782200 PMC: 11270650. DOI: 10.1016/j.kint.2024.04.017.


Targeting Ras with protein engineering.

Tomazini A, Shifman J Oncotarget. 2023; 14:672-687.

PMID: 37395750 PMC: 10317039. DOI: 10.18632/oncotarget.28469.


Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.

Salla M, Guo J, Joshi H, Gordon M, Dooky H, Lai J Int J Mol Sci. 2023; 24(6).

PMID: 36983040 PMC: 10055751. DOI: 10.3390/ijms24065967.